Cargando…
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
BACKGROUND AND AIMS: Severe sepsis and septic shock are common causes of mortality and morbidity in an intensive care unit setting. Endotoxin, derived from the outer membranes of Gram-negative bacteria, is considered a major factor in the pathogenesis of sepsis. This study investigated the effect of...
Autores principales: | Shum, Hoi Ping, Leung, Yuk Wah, Lam, Sin Man, Chan, King Chung, Yan, Wing Wa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271277/ https://www.ncbi.nlm.nih.gov/pubmed/25538412 http://dx.doi.org/10.4103/0972-5229.146305 |
Ejemplares similares
-
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, HP, et al.
Publicado: (2013) -
Abdominal Septic Shock – Endotoxin Adsorption Treatment (ASSET) – endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial
por: Lipcsey, Miklos, et al.
Publicado: (2016) -
Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020) -
Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004) -
Treatment of Acute Kidney Injury Complicating Septic Shock with EMiC2 High-cutoff Hemofilter: Case Series
por: Shum, Hoi-Ping, et al.
Publicado: (2017)